PI(20:3(5Z,8Z,11Z)/20:3(8Z,11Z,14Z))

Term ID

CHEBI:89136

Synonyms

1-(5Z,8Z,11Z-Eicosatrienoyl)-2-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phospho-(1'-myo-inositol)
1-Meadoyl-2-homo-g-linolenoyl-sn-glycero-3-phosphoinositol
1-Meadoyl-2-homo-gamma-linolenoyl-sn-glycero-3-phosphoinositol
[(2R)-3-[(5Z,8Z,11Z)-icosa-5,8,11-trienoyloxy]-2-[(8Z,11Z,14Z)-icosa-8,11,14-trienoyloxy]propoxy]({[(1s,3R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy})phosphinic acid
Phosphatidylinositol(20:3/20:3)
Phosphatidylinositol(20:3n9/20:3n6)
Phosphatidylinositol(20:3w9/20:3w6)
Phosphatidylinositol(40:6)
PI(20:3/20:3)
PI(20:3n9/20:3n6)
PI(20:3w9/20:3w6)
PI(40:6)
PIno(20:3/20:3)
PIno(20:3n9/20:3n6)
PIno(20:3w9/20:3w6)
PIno(40:6)

(all 16)

Definition

References

(all 4)

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from PI(20:3(5Z,8Z,11Z)/20:3(8Z,11Z,14Z))

No data available

Phenotype where environments contain PI(20:3(5Z,8Z,11Z)/20:3(8Z,11Z,14Z))

No data available

Phenotype modified by environments containing PI(20:3(5Z,8Z,11Z)/20:3(8Z,11Z,14Z))

Phenotype affecting PI(20:3(5Z,8Z,11Z)/20:3(8Z,11Z,14Z))

Human Disease Model